| Author | Moraes, Milton Ozório | |
| Access date | 2019-07-02T17:22:40Z | |
| Available date | 2019-07-02T17:22:40Z | |
| Document date | 2016 | |
| Citation | MORAES, Milton Ozório. Drug-resistance in leprosy: moving toward understanding the scope of the problem and how to tackle it. Clinical Infectious Diseases, v. 63, n. 11, p. 1485-1486, 1 Dec. 2016. | |
| ISSN | 1058-4838 | |
| URI | https://www.arca.fiocruz.br/handle/icict/33782 | |
| Description | Produção científica do Laboratório de Hanseníase. | pt_BR |
| Language | eng | en_US |
| Publisher | Oxford University Press | |
| Rights | open access | |
| Title | Drug-resistance in leprosy: moving toward understanding the scope of the problem and how to tackle it | en_US |
| Type | Article | |
| DOI | 10.1093/cid/ciw574 | |
| Abstract | Leprosy is an infectious disease caused by Mycobacterium leprae, a bacterium that infects Schwann cells in the peripheral nervous system and macrophages in the skin. Leprosy presents primarily as a peripheral neuropathy but may lead to deformities if it progresses without treatment. Leprosy cases are classified as paucibacillary if the patient has 5 or fewer skin lesions and low bacterial counts or as multibacillary if the patient has more than 5 lesions and high bacterial counts. The complexity of clinical presentations has hindered the development of an easy diagnostic test. | en_US |
| Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ. Brasil. | |
| Subject | Antimicrobial resistance | en_US |
| Subject | Rifampicin | en_US |
| Subject | Dapsone | en_US |
| Subject | Multidrug treatment | en_US |
| Subject | Tuberculosis | en_US |
| e-ISSN | 1537-6591 | |
